CRIS Current Research Information System

VIGNATELLI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.809
AS - Asia 3.523
EU - Europa 2.522
AF - Africa 210
SA - Sud America 154
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.758
SG - Singapore 998
CN - Cina 893
VN - Vietnam 885
GB - Regno Unito 614
IT - Italia 372
DE - Germania 324
SE - Svezia 300
HK - Hong Kong 233
UA - Ucraina 183
IN - India 161
FR - Francia 156
RU - Federazione Russa 127
KR - Corea 113
BR - Brasile 108
IE - Irlanda 89
NL - Olanda 87
FI - Finlandia 80
TG - Togo 80
JP - Giappone 65
ZA - Sudafrica 45
CI - Costa d'Avorio 32
EE - Estonia 28
CH - Svizzera 27
BE - Belgio 26
SC - Seychelles 25
CA - Canada 23
AR - Argentina 21
ES - Italia 21
PK - Pakistan 21
MX - Messico 20
PH - Filippine 20
TH - Thailandia 18
BG - Bulgaria 16
AT - Austria 14
BD - Bangladesh 14
ID - Indonesia 13
PL - Polonia 13
JO - Giordania 12
UZ - Uzbekistan 12
TW - Taiwan 11
CO - Colombia 10
RO - Romania 10
GR - Grecia 9
IQ - Iraq 9
LT - Lituania 8
TR - Turchia 8
SA - Arabia Saudita 6
TN - Tunisia 6
IR - Iran 5
NZ - Nuova Zelanda 5
CL - Cile 4
EG - Egitto 4
HR - Croazia 4
LB - Libano 4
MA - Marocco 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EC - Ecuador 3
GH - Ghana 3
MY - Malesia 3
NG - Nigeria 3
PT - Portogallo 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
PE - Perù 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
HU - Ungheria 1
LK - Sri Lanka 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
TO - Tonga 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.229
Salva come PNG Salva come JPEG
Città #
Singapore 715
Southend 505
Ashburn 434
Chandler 318
Ann Arbor 252
Fairfield 252
Hefei 248
Ho Chi Minh City 223
Hong Kong 217
Santa Clara 203
Hanoi 199
San Jose 173
Jacksonville 131
Woodbridge 130
Wilmington 124
Houston 117
Seattle 108
Princeton 107
Seoul 98
Cambridge 96
Dallas 96
Dublin 88
Beijing 87
Boardman 86
Lomé 80
Bologna 72
Los Angeles 71
Helsinki 68
Dong Ket 63
Tokyo 62
Lauterbourg 55
Padova 45
Westminster 44
Council Bluffs 42
New York 39
Berlin 38
Redmond 35
Jinan 34
Turin 34
Nanjing 33
Abidjan 32
Haiphong 32
Da Nang 31
Bengaluru 28
Milan 27
Brussels 26
Saint Petersburg 26
Buffalo 25
Bern 24
Shenyang 23
Medford 21
London 19
Redondo Beach 19
Hebei 17
Mülheim 17
Redwood City 17
Tianjin 17
Sofia 16
Yubileyny 15
Des Moines 14
Mahé 14
São Paulo 14
Johannesburg 13
Frankfurt am Main 12
Guangzhou 12
Munich 12
Nanchang 12
Orem 12
San Diego 12
Zhengzhou 12
Amman 11
Lahore 11
Rome 11
Verona 11
Amsterdam 10
Can Tho 10
Changsha 10
Chicago 10
Jiaxing 10
Nha Trang 10
Norwalk 10
Chengdu 9
Hải Dương 9
Lappeenranta 9
Olalla 9
Shanghai 9
Toronto 9
Vienna 9
Xi'an 9
Bangkok 8
Brooklyn 8
Montreal 8
Nuremberg 8
Atlanta 7
Boston 7
Bremen 7
Bắc Ninh 7
Denver 7
Quận Bình Thạnh 7
Warsaw 7
Totale 6.660
Salva come PNG Salva come JPEG
Nome #
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units 274
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment 251
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. 241
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis 223
Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. 206
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 201
Memoria semantica durante il sonno REM di pazienti narcolettici 197
Community-onset pediatric status epilepticus: Barriers to care and outcomes in a real-world setting 196
Mesial temporal lobe epilepsy (MTLE): prognostic factors 196
Medico-legal assessment of disability in narcolepsy: an interobserver reliability study 196
Magnetic resonance imaging scoring system of the lower limbs in adult patients with suspected idiopathic inflammatory myopathy 192
Parasomnias versus epilepsy: common grounds and a need to change the approach to the problem. 188
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management 188
Role of Daytime Continuous Polysomnography in the Diagnosis of Pediatric Narcolepsy Type 1 187
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: A prospective study 187
Antidepressant drugs for narcolepsy 185
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. 185
Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. 185
Prognostic factors in patients with mesial temporal lobe epilepsy 183
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 183
Quality of life, eating and mood disorders in menstrual migraine: a case-control study 181
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 178
Semantic memory during REM sleep of narcoleptic patients 177
Diagnosis of Nocturnal Frontal Lobe Seizures: The Diagnostic Accuracy of Clinical History. 176
Sex disparities in clinical features and burden of narcolepsy type 1 174
Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR) 172
Work productivity and activity impairment in patients with narcolepsy type 1 169
Memoria procedurale e dichiarativa durante il sonno di pazienti narcolettici 168
Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. 167
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 167
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. 165
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 165
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment 163
Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS 161
Antidepressant drugs for narcolepsy. 161
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 160
Sleep and time course of consolidation of visual discrimination skills in patients with narcolepsy-cataplexy. 159
Interobserver reliability of ICSD-R minimal diagnostic criteria for the parasomnias. 158
Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study 153
Health-related quality of life in patients with Nocturnal Frontal Lobe Epilepsy. 152
Interobserver reliability of video recording in the diagnosis of nocturnal frontal lobe seizures. 152
Interobserver reliability of video-polysomnographic diagnosis of Nocturnal Frontal Lobe seizures. 148
Frequency of Parasomnias in patients with Nocturnal Frontal Lobe Epilepsy (NFLE) and their relatives. 147
A pragmatic approach to test the reliaility af permanent impairment classification 147
L'analisi dell'accordo fra osservatori e delle fonti di variabilità come strumento per il miglioramento della qualità in medicina legale 144
Patient-centred estimation of multimorbidity in chronic disease populations: a novel approach integrating global burden of disease metrics and healthcare administrative data 141
Resilience and its correlates in patients with narcolepsy type 1 141
L'analisi dell'accordo fra osservatori e delle fonti di variabilità come strumento per il miglioramento della qualità in medicina legale 141
Heart Rate Variability as a Tool for Seizure Prediction: A Scoping Review 140
Nocturnal baroreflex sensitivity and heart rate variability are markers of excessive daytime sleepiness in sleep related breathing disorders. 140
Diagnostic accuracy of clinical history in the diagnosis of Nocturnal Frontal Lobe seizures. 138
Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. 138
Nocturnal frontal lobe epilepsy and arousal disorders: chance association or common mechanisms? 133
Impaired cortical and autonomic arousal during sleep in multiple system atrophy. 132
Restless legs syndrome and periodic limb movement disorder 128
Valutazione medico-legale del danno biologico nella persona anziana. I risultati della consensus conference multidisciplinare 112
Reliability of narcolepsy assessment for disability benefit 111
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients 104
Interobserver reliability in the assessment of disablement in patients with narcolepsy 97
Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort 95
Interrater reliability as quantitative end-point for legal medicine in work ability assessment: a lesson from an epidemiological study applied to a neurological disease 85
null 85
Epidemiological survey on status epilepticus in Bologna and Lugo di Romagna: Incidence, prognosis and treatment 70
Reliability and diagnostic accuracy of home video recording in differentiating sleep-related hypermotor epilepsy from disorders of arousal 53
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 46
The challenge of ultra-rarity: Dual diagnosis of Lafora disease and developmental encephalopathies linked to TRIO and SHANK3 pathogenic variants 36
Letter to the Editor: “Record-Linkage in Population Studies on Epilepsy: Pros and Cons” 28
New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment 23
null 1
Totale 10.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021215 0 0 0 0 0 0 0 0 0 44 52 119
2021/20221.091 96 52 67 73 87 62 29 66 37 121 233 168
2022/20231.240 127 220 78 160 78 98 29 63 178 41 99 69
2023/2024429 45 64 27 60 29 78 16 31 10 32 13 24
2024/20251.442 55 211 118 101 259 70 87 32 15 97 76 321
2025/20263.731 460 412 375 297 453 202 385 110 753 284 0 0
Totale 10.426